Dr. Thompson’s Lab published a study on different Beta Cells dysfunction and their respective therapeutic targets in preventing Type 1 Diabetes: “We discuss opportunities and important open questions around the effectiveness of beta cell therapies and challenges for clinical utility. We further evaluate ways in which beta cell drug therapy could be combined with immunotherapy for preventing T1D in light of our growing appreciation of disease heterogeneity and patient endotypes.”
CLICK HERE for the full article
What's New
All Articles
New Training Opportunity for Indigenous Undergraduate Students
Are you an Indigenous student interested in learning how to do research? The University of Manitoba is now offering a…
Now Recruiting Participants for a Research Study!
Study title: Monitoring markers of survivor beta cell function and stress in recently diagnosed type 1 diabetes Is your child…
UM Knowledge Exchange: Type 2 Diabetes in Children
On Wednesday May 8, 2024, UM Knowledge Exchange explored the factors contributing to the development of type 2 diabetes in…
Cardiorespiratory Fitness and Physical Activity in Pediatric Diabetes
Are cardiorespiratory fitness (CRF) and physical activity lower among youths with diabetes compared with youths without diabetes? In this systematic…
Establishing evidence for immune surveillance of β-cell senescence
Cellular senescence is a programmed state of cell cycle arrest that involves a complex immunogenic secretome, eliciting immune surveillance and…
Factors Affecting Quality of Life in Adolescents Living with Type 2 Diabetes: A Sub study of The Improving renal Complications in Adolescents with type 2 diabetes through REsearch cohort
Type 2 diabetes (T2D) impacts adolescents living in challenging socioeconomic conditions disproportionately. However, impacts of T2D on quality of life…